Literature DB >> 25364550

Fluctuation in the Levels of Immunoglobulin M and Immunoglobulin G Antibodies for Cardiolipin and β2-Glycoprotein among Healthy Pregnant Women.

Mohammed S Al-Balushi1, Sidgi S Hasson1, Elias A Said1, Juma Z Al-Busaidi1, Muna S Al-Daihani1, Mohammed S Othman1, Talal A Sallam2, Mohammed A Idris1, Moza Al-Kalbani3, Nicholas Woodhouse4, Ali A Al-Jabri1.   

Abstract

OBJECTIVES: Antiphospholipid antibodies fluctuate during a healthy normal pregnancy. This study aimed to investigate the levels of both immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies for cardiolipin and β2-glycoprotein (β2GP) among healthy pregnant women.
METHODS: This study was conducted between May 2010 and December 2012. A total of 75 healthy Omani pregnant women with no history of autoimmune disease were investigated during their pregnancy and 90 days after delivery at the Armed Forces Hospital in Muscat, Oman. A control group of 75 healthy Omani non-pregnant women were also investigated as a comparison. Levels of IgM and IgG antibodies for both anti-cardiolipin antibodies (ACAs) and β2GP were measured using a standard enzyme-linked immunosorbent assay.
RESULTS: The ACA IgM levels were significantly higher in the control group compared to the pregnant women (P <0.001). No significant differences were observed in the ACA IgM levels between the control group and the pregnant women after delivery. In contrast, ACA IgG levels were significantly higher during pregnancy and after delivery compared with those of the healthy control group (P = 0.007 and 0.002, respectively). The levels of β2GP IgG were significantly higher during pregnancy than after delivery and in the control group (P = 0.001 and <0.001, respectively).
CONCLUSION: In this study, ACA IgG levels increased during healthy pregnancies and after normal deliveries whereas β2GP IgG levels increased transiently during the pregnancies. Both phenomena were found to be significantly associated with a transient decline in the levels of IgM specific for these antigens. Therefore, the levels of these antibodies may be regulated during a healthy pregnancy.

Entities:  

Keywords:  Anticardiolipin Antibodies; Oman; Pregnancy; Women; beta 2-Glycoprotein I

Year:  2014        PMID: 25364550      PMCID: PMC4205059     

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  31 in total

Review 1.  The antiphospholipid syndrome.

Authors:  Jerrold S Levine; D Ware Branch; Joyce Rauch
Journal:  N Engl J Med       Date:  2002-03-07       Impact factor: 91.245

Review 2.  Antiphospholipid antibodies and pregnancy.

Authors:  Monica Galli; Tiziano Barbui
Journal:  Best Pract Res Clin Haematol       Date:  2003-06       Impact factor: 3.020

3.  Outcomes and treatment of obstetrical antiphospholipid syndrome in women with low antiphospholipid antibody levels.

Authors:  Arsene Mekinian; Priscille Loire-Berson; Pascale Nicaise-Roland; Eric Lachassinne; Jerome Stirnemann; Marie-Claire Boffa; Sylvie Chollet-Martin; Lionel Carbillon; Olivier Fain
Journal:  J Reprod Immunol       Date:  2012-03-03       Impact factor: 4.054

4.  Prevalence of elevated anticardiolipin antibodies in pregnant women with unexplained elevations of alpha-fetoprotein.

Authors:  D L Yetman; W H Kutteh; R Castorena; C Brown; L Baskin
Journal:  J Reprod Immunol       Date:  1997-04       Impact factor: 4.054

5.  Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.

Authors:  M Inanç; S Donohoe; C T Ravirajan; E L Radway-Bright; I Mackie; S Machin; D A Isenberg
Journal:  Br J Rheumatol       Date:  1998-10

6.  Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-control study.

Authors:  C Infante-Rivard; M David; R Gauthier; G E Rivard
Journal:  N Engl J Med       Date:  1991-10-10       Impact factor: 91.245

7.  Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study.

Authors:  A Lynch; R Marlar; J Murphy; G Davila; M Santos; J Rutledge; W Emlen
Journal:  Ann Intern Med       Date:  1994-03-15       Impact factor: 25.391

8.  Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience.

Authors:  D W Branch; R M Silver; J L Blackwell; J C Reading; J R Scott
Journal:  Obstet Gynecol       Date:  1992-10       Impact factor: 7.661

Review 9.  The Th1:th2 dichotomy of pregnancy and preterm labour.

Authors:  Lynne Sykes; David A MacIntyre; Xiao J Yap; Tiong Ghee Teoh; Phillip R Bennett
Journal:  Mediators Inflamm       Date:  2012-06-07       Impact factor: 4.711

10.  Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface.

Authors:  E Matsuura; Y Igarashi; T Yasuda; D A Triplett; T Koike
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

View more
  1 in total

1.  Evaluation of Frequency, Clinical Correlation, and Antibodies Confirmation Profile in Patients with Suspected Antiphospholipid Syndrome.

Authors:  Filipe F Martins; Teresa M L Campos
Journal:  TH Open       Date:  2021-10-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.